# The Comparison of Effects Between Increased Dose of Clopidogrel and Addition of Cilostazol

> **NCT00620646** · NA · COMPLETED · sponsor: **Samsung Medical Center** · enrollment: 80 (estimated)

## Conditions studied

- Clopidogrel Non-Responsiveness

## Interventions

- **DRUG:** aspirin, clopidogrel
- **DRUG:** aspirin, clopidogrel, cilostazol

## Key facts

- **NCT ID:** NCT00620646
- **Lead sponsor:** Samsung Medical Center
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-02
- **Primary completion:** 2008-12
- **Final completion:** 2009-02
- **Target enrollment:** 80 (ESTIMATED)
- **Last updated:** 2009-02-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00620646

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00620646, "The Comparison of Effects Between Increased Dose of Clopidogrel and Addition of Cilostazol". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00620646. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*